SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Becher Peter Moritz)
 

Search: WFRF:(Becher Peter Moritz) > (2022) > Use of evidence-bas...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata

Stolfo, Davide (author)
Karolinska Institutet,Karolinska Inst, Sweden; Cardiothoracovasc Dept, Italy; Univ Trieste, Italy
Lund, Lars H. (author)
Karolinska Institutet,Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden
Becher, Peter Moritz (author)
Karolinska Inst, Sweden; Univ Heart & Vasc Ctr Hamburg, Germany; German Ctr Cardiovasc Res DZHK, Germany
show more...
Orsini, Nicola (author)
Karolinska Institutet,Karolinska Inst, Sweden
Thorvaldsen, Tonje (author)
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden
Benson, Lina (author)
Karolinska Institutet,Karolinska Inst, Sweden
Hage, Camilla (author)
Karolinska Institutet,Karolinska Inst, Sweden
Dahlström, Ulf (author)
Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US
Sinagra, Gianfranco (author)
Cardiothoracovasc Dept, Italy; Univ Trieste, Italy
Savarese, Gianluigi (author)
Karolinska Institutet,Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden
show less...
 (creator_code:org_t)
2022-04-03
2022
English.
In: European Journal of Heart Failure. - : Wiley. - 1388-9842 .- 1879-0844. ; 24:6, s. 1047-1062
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aims In older patients, guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (<40%; HFrEF) is not contraindicated, but adherence to guidelines is limited. We investigated the implementation of GDMT in HFrEF across different age strata in a large nationwide cohort. Methods and results Patients with HFrEF and HF duration >= 3 months registered in the Swedish HF Registry between 2000-2018 were analysed according to age. Multivariable logistic and multinomial regressions were fitted to investigate factors associated with underuse/underdosing. Of 27 430 patients, 31% were <70 years old, 34% 70-79 years old, and 35% >= 80 years old. Use of treatments progressively decreased with increasing age. Use of renin-angiotensin system/angiotensin receptor-neprilysin inhibitors, beta-blockers and mineralocorticoid receptor antagonists was 80%, 88% and 35% in age >= 80 years; 90%, 93% and 47% in age 70-79 years; and 95%, 95% and 54% in age <70 years, respectively. Among patients with an indication, use of implantable cardioverter defibrillator and cardiac resynchronization therapy (CRT) was 7% and 23% in age >= 80 years; 22% and 42% in age 70-79 years; and 29% and 50% in age <70 years, respectively. Older patients were less likely treated with target doses or combinations of HF medications. Except for CRT, after extensive adjustments, age was inversely associated with the likelihood of GDMT use and target dose achievement. Conclusion In HFrEF, gaps persist in the use of medications and devices. In disagreement with current recommendations, older patients remain undertreated. Improving strategies and a more individualized approach for implementing use of GDMT in HFrEF are required, particularly in older patients.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

Elderly; Heart failure with reduced ejection fraction; Guideline-directed medical therapy

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view